Omega-3 fatty acids may help to reduce the physical harm caused by smoking
Omega-3 fatty acids may help to reduce the physical harm caused by smoking, according to a new study presented at the World Congress of Cardiology.
The study, carried out in Greece, assessed the effect of four-week oral treatment with 2 g/day of omega-3 fatty acids on the arterial wall properties of cigarette smokers. The results showed that short-term treatment with omega-3 fatty acids improves arterial stiffness and moderates the acute smoking-induced impairment of vascular elastic properties in smokers.
"These findings suggest that omega-3 fatty acids inhibit the detrimental effects of smoking on arterial function, which is an independent prognostic marker of cardiovascular risk," said Dr. Gerasimos Siasos, University of Athens Medical School, 1st Department of Cardiology, "Hippokration" Hospital. "The cardioprotective effects of omega-3 fatty acids appear to be due to a synergism between multiple, intricate mechanisms involving anti-inflammatory and anti-atherosclerotic effects. Furthermore, AHA recommends that people without documented history of coronary heart disease should consume a variety of fish (preferably oily rich in omega-3 fatty acids) at least twice per week."
"The World Heart Federation strongly encourages all smokers to quit," said Dr Kathryn Taubert, Chief Science Officer at the World Heart Federation. "The only way to protect your body from the harmful effects of tobacco is to stop smoking. We encourage all people, both smokers and non-smokers, to eat healthy diets, which includes foods rich in omega-3 fatty acids."
Provided by World Heart Federation
-
Fatty fish protects against prostate cancer
Oct 31, 2006 |
not rated yet |
0
-
Study: Smoking hikes blinding disease risk
Jul 11, 2006 |
not rated yet |
0
-
Eating fish and foods with omega-3 fatty acids linked to lower risk of age-related eye disease
Jun 09, 2008 |
not rated yet |
0
-
Columbia research shows novel benefits of fatty acids in arteries
Feb 05, 2009 |
not rated yet |
0
-
Omega-3 fatty acids protect against Parkinson's, study says
Nov 26, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Question of reflection and transmission of TEM wave in normal incidenc
2 hours ago
-
the rudyak-krasnolutski effective potencial
3 hours ago
-
Normal force for a lever model
4 hours ago
-
gravity is std. therefore can we rate a 'mass at height' by watts?
10 hours ago
-
Calculating on-axis elements of a solenoid
22 hours ago
-
latitude & longitude & air pressure
23 hours ago
- More from Physics Forums - Classical Physics
More news stories
Dual-source cardiac CT IDs CAD in hard-to-image patients
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Cardiology
1 hour ago |
not rated yet |
0
Death rates decline for advanced heart failure patients, but outcomes are still not ideal
UCLA researchers examining outcomes for advanced heart-failure patients over the past two decades have found that, coinciding with the increased availability and use of new therapies, overall mortality has decreased and sudden ...
Cardiology
3 hours ago |
not rated yet |
0
Second-generation TAVI device—Lotus Valve—shows good performance in REPRISE II
22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...
Cardiology
8 hours ago |
not rated yet |
0
Costs to treat stroke in America may double by 2030
Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association.
Cardiology
May 22, 2013 |
not rated yet |
0
New blood-thinner measures may cut medication errors
Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...
Cardiology
May 22, 2013 |
not rated yet |
0
Glucosamine supplements tied to risk of eye condition
(HealthDay)—Glucosamine supplements that millions of Americans take to help treat hip and knee osteoarthritis may have an unexpected side effect: They may increase risk for developing glaucoma, a small ...
Controlling mood through the motions of mitochondria
(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...
WHO: Scientific red tape mars efforts vs. virus
International efforts to combat a new pneumonia-like virus that has now killed 22 people are being slowed by unclear rules and competition for the potentially profitable rights to disease samples, the head ...
Future doctors unaware of their obesity bias
Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...
Scientists discover molecule triggers sensation of itch
Scientists at the National Institutes of Health report they have discovered in mouse studies that a small molecule released in the spinal cord triggers a process that is later experienced in the brain as ...
Multiple research teams unable to confirm high-profile Alzheimer's study
Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.